Endonovo Therapeutics, Inc. (ENDV)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 9, 2026, 3:05 PM EST
Endonovo Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 - 2013 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 - 2013 |
| Net Income | -4.4 | -18.47 | -3.1 | -0.4 | -17.31 | -6.44 | Upgrade
|
| Depreciation & Amortization | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | 0.65 | Upgrade
|
| Other Amortization | 0.03 | 0.11 | 0.14 | 0.23 | 2.24 | 3.56 | Upgrade
|
| Stock-Based Compensation | 1 | 1.36 | 0.1 | 0.46 | 0.19 | 0.63 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | 0 | - | - | - | - | Upgrade
|
| Other Operating Activities | 0.53 | 13.67 | 0.01 | -3.57 | 10.07 | -2.16 | Upgrade
|
| Change in Accounts Receivable | - | - | -0 | 0.02 | -0.02 | -0 | Upgrade
|
| Change in Accounts Payable | 0.02 | 0.27 | -0.04 | 0.09 | 0.44 | 0.06 | Upgrade
|
| Change in Other Net Operating Assets | 1.55 | 1.74 | 1.27 | 1.77 | 1.2 | 0.82 | Upgrade
|
| Operating Cash Flow | -0.63 | -0.68 | -0.99 | -0.74 | -2.54 | -2.88 | Upgrade
|
| Capital Expenditures | - | - | - | - | -0 | -0.01 | Upgrade
|
| Investing Cash Flow | - | - | - | - | -0 | -0.01 | Upgrade
|
| Short-Term Debt Issued | - | - | - | - | - | 0.07 | Upgrade
|
| Long-Term Debt Issued | - | 0.47 | 0.95 | 0.61 | 2 | 2.84 | Upgrade
|
| Total Debt Issued | 0.26 | 0.47 | 0.95 | 0.61 | 2 | 2.9 | Upgrade
|
| Short-Term Debt Repaid | - | -0.01 | -0.02 | -0.02 | -0.11 | -0.09 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.13 | -0.56 | Upgrade
|
| Total Debt Repaid | -0.05 | -0.01 | -0.02 | -0.02 | -0.24 | -0.65 | Upgrade
|
| Net Debt Issued (Repaid) | 0.21 | 0.45 | 0.93 | 0.59 | 1.76 | 2.25 | Upgrade
|
| Issuance of Common Stock | 0.4 | 0.14 | 0.13 | 0.1 | 0.17 | 0.79 | Upgrade
|
| Financing Cash Flow | 0.61 | 0.59 | 1.06 | 0.74 | 2.18 | 3.18 | Upgrade
|
| Net Cash Flow | -0.02 | -0.09 | 0.07 | -0.01 | -0.36 | 0.29 | Upgrade
|
| Free Cash Flow | -0.63 | -0.68 | -0.99 | -0.74 | -2.54 | -2.89 | Upgrade
|
| Free Cash Flow Margin | -246.32% | -501.52% | -1349.54% | -447.29% | -820.08% | -3468.29% | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.06 | -3.65 | -7.97 | Upgrade
|
| Cash Interest Paid | - | - | - | 0.03 | 0.02 | 0.25 | Upgrade
|
| Levered Free Cash Flow | 2.15 | 14.95 | -0.74 | -6.53 | 4.19 | -2.04 | Upgrade
|
| Unlevered Free Cash Flow | 2.88 | 15.66 | -0.3 | -5.46 | 5.95 | -2.25 | Upgrade
|
| Change in Working Capital | 1.57 | 2.01 | 1.22 | 1.89 | 1.62 | 0.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.